報價延遲最少15分鐘:2025/01/21 08:54 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
-- 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.95/-1.27
|
|
企業價值
4.19B
|
| 資產負債 |
|
每股賬面淨值
4.46
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
6.17M
|
|
每股收益
2.15
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 08:54 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces. |